₹ 1,193.00
4.90 (0.41%)
Z
Zydus Life Science
₹ 1,193.00
Zydus Life Science Share Price Today
Zydus Life Science (ZYDUSLIFE) share price is trading at ₹1,193.00 on the NSE as of November 5, 2026 at 03:58 PM, up by 0.41% from its previous close of ₹1,188.10. In todays trading session ZYDUSLIFE reached a high of 1,204.90 and low of 1,172.00. The average traded price for today is 1,190.88. The 50 DMA stands at 1,156.05 and 200 DMA is at 1,039.06. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : ZYDUSLIFE
- Open : ₹1,200.00
- Previous Close : ₹1,188.10
- Day's Range : ₹1,172.00 – ₹1,204.90
- 52-Week Range : ₹835.50 – ₹1,266.60
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
ZYDUSLIFE Stock Performance
Markets Today
High
1,204.90
Low
1,172.00
Open at
1,200.00
Prev Close
1,188.10
Volumes
23,09,691
Avg Price
1,190.88
Lower Circuit
1,073.70
Upper Circuit
1,312.30
Last Traded Details
Quantity
50
Time
15:58:47
Price Movement
Historical Performance
3 M High
1,266.60
3 M Low
1,086.00
1 Yr High
1,266.60
1 Yr Low
835.50
3 Yr High
1,324.30
3 Yr Low
579.35
5 Yr High
1,324.30
5 Yr Low
319.00
1-Year Performance
ZYDUSLIFE Pros and Cons
Consolidated revenue grew from ₹65,737 Cr to ₹80,170 Cr from Q1 FY26 to Q1 FY27, confirming strong top-line momentum
Gross margin improved from 72.8% to 74.0% from Q1 FY26 to Q4 FY26, reflecting robust cost management
Glucon-D and Sugar Free held market rank 1 from Q1 FY26 through Q1 FY27, maintaining unchallenged category leadership
R&D spending rose from ₹4,856 Cr to ₹6,982 Cr from Q1 FY26 to Q4 FY26, accelerating innovation pipeline execution
North America regulatory approvals increased from 6 to 9 from Q1 FY26 to Q4 FY26, expanding US market access
EBITDA margin fell from 33.7% to 24.1% from Q4 FY26 to Q1 FY27, showing profit compression
North America sales share dropped from 49% to 10% from Q1 FY26 to Q1 FY27, signaling a major portfolio mix shift
Net debt climbed from -₹56,312 Cr to ₹43,050 Cr from Q1 FY26 to Q4 FY26, indicating rising leverage
Net forex losses widened from -₹571 Cr to -₹6,449 Cr from Q1 FY26 to Q4 FY26, highlighting persistent currency headwinds
Other operating expenses rose from ₹13,648 Cr to ₹18,732 Cr from Q1 FY26 to Q4 FY26, pressuring bottom-line efficiency
ZYDUSLIFE Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 29 analysts
Buy
51.72%
Hold
24.14%
Sell
24.14%
Get forecast for Price, ROA & ROE based on analyst ratings.
ZYDUSLIFE Share Price History
ZYDUSLIFE Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,19,002
PE Ratio
27.60
PB Ratio
4.27
Dividend Yield
0.08%
ROE
16.99%
ROCE
19.24%
Book Value (₹)
278.87
Face Value (₹)
1.00
Analyse ZYDUSLIFE with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 74.99% | 75.00% | 75.00% | 75.01% | 75.01% |
| Domestic Institutional Investors (DII) | 10.86% | 11.09% | 11.20% | 11.27% | 11.28% |
| Foreign Institutional Investors (FII) | 7.34% | 7.06% | 6.95% | 6.88% | 7.05% |
| Public Investors | 5.49% | 5.54% | 5.54% | 5.45% | 5.30% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Zydus Life Science Return Calculator
Note: Past profits do not guarantee future returns.
ZYDUSLIFE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
ZYDUSLIFE Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for ZYDUSLIFE
Margin on ZYDUSLIFE
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
ZYDUSLIFE Financials Summary
In Crores
ZYDUSLIFE Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check ZYDUSLIFE latest Company Filings, Investor Presentation & Conference Call details.
ZYDUSLIFE Revenue Growth
All values are in Crores
Revenue
Profit
Loss
ZYDUSLIFE Options Snapshot
ZYDUSLIFE Futures Snapshot
Use from 12+ Pre-built Strategies or Build Your Own to trade ZYDUSLIFE FnO contracts.
ZYDUSLIFE Similar Stocks
FAQs on ZYDUSLIFE
What is the share price of Zydus Life Science?
What is the 52W high and 52W low of Zydus Life Science?
What is the return on Zydus Life Science share?
- Past 1 year: 22.77%
- Past 3 years: 103.98%
- Past 5 years: 142.60%
What is the PE and PB Ratio of Zydus Life Science?
What is the EPS of Zydus Life Science?
What is the shareholding pattern of Zydus Life Science?
- DIIs - 11.28%
- FII - 7.05%
- Promoters - 75.01%
- Public Investors 5.30%
- Goverenment - 0.00%
How to buy Zydus Life Science shares online?
How to buy Zydus Life Science shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Zydus Life Science share
- Tap on “Buy”
Option Chain